119 related articles for article (PubMed ID: 20063559)
1. Studies on biomarkers for oxidative stress in patients with chronic myeloid leukemia.
Singh RK; Tripathi AK; Tripathi P; Singh S; Singh R; Ahmad R
Hematol Oncol Stem Cell Ther; 2009; 2(1):285-8. PubMed ID: 20063559
[TBL] [Abstract][Full Text] [Related]
2. Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia.
Ahmad R; Tripathi AK; Tripathi P; Singh S; Singh R; Singh RK
In Vivo; 2008; 22(4):525-8. PubMed ID: 18712183
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and antioxidant status in patients with chronic myeloid leukemia.
Ahmad R; Tripathi AK; Tripathi P; Singh R; Singh S; Singh RK
Indian J Clin Biochem; 2008 Oct; 23(4):328-33. PubMed ID: 23105780
[TBL] [Abstract][Full Text] [Related]
4. Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia.
Ahmad R; Tripathi AK; Tripathi P; Singh R; Singh S; Singh RK
Singapore Med J; 2010 Feb; 51(2):110-5. PubMed ID: 20358148
[TBL] [Abstract][Full Text] [Related]
5. Assessment of oxidative stress in chronic pancreatitis patients.
Verlaan M; Roelofs HM; van-Schaik A; Wanten GJ; Jansen JB; Peters WH; Drenth JP
World J Gastroenterol; 2006 Sep; 12(35):5705-10. PubMed ID: 17007026
[TBL] [Abstract][Full Text] [Related]
6. Interaction between oxidative stress and smoking is associated with an increased risk of rheumatoid arthritis: a case-control study.
Navarro-Compán V; Melguizo-Madrid E; Hernández-Cruz B; Santos-Rey K; Leyva-Prado C; González-Martín C; Navarro-Sarabia F; González-Rodríguez C
Rheumatology (Oxford); 2013 Mar; 52(3):487-93. PubMed ID: 23148091
[TBL] [Abstract][Full Text] [Related]
7. Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.
Pietarinen PO; Eide CA; Ayuda-Durán P; Potdar S; Kuusanmäki H; Andersson EI; Mpindi JP; Pemovska T; Kontro M; Heckman CA; Kallioniemi O; Wennerberg K; Hjorth-Hansen H; Druker BJ; Enserink JM; Tyner JW; Mustjoki S; Porkka K
Oncotarget; 2017 Apr; 8(14):22606-22615. PubMed ID: 28186983
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress markers in pre-uremic patients.
Annuk M; Fellström B; Akerblom O; Zilmer K; Vihalemm T; Zilmer M
Clin Nephrol; 2001 Oct; 56(4):308-14. PubMed ID: 11680661
[TBL] [Abstract][Full Text] [Related]
9. Molecular detection of survivin expression, antiapoptotic gene, and other prognostic markers, how they are correlated and how it could be of prognostic value in chronic myeloid leukemia patient.
Zhara M; Mourad H; Farouk G; Elbatch M; Ezzat S; Sami W
Egypt J Immunol; 2007; 14(2):51-62. PubMed ID: 20306657
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood leucocytes ornithine decarboxylase activity in chronic myeloid leukemia patients: prognostic and therapeutic implications.
Tripathi AK; Chaturvedi R; Ahmad R; Asim M; Sawlani KK; Singh RL; Tekwani BL
Leuk Res; 2002 Apr; 26(4):349-54. PubMed ID: 11839377
[TBL] [Abstract][Full Text] [Related]
11. Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls.
de Cássia Viu Carrara R; Fontes AM; Abraham KJ; Orellana MD; Haddad SK; Palma PVB; Panepucci RA; Zago MA; Covas DT
Clin Transl Oncol; 2018 Apr; 20(4):542-549. PubMed ID: 28905209
[TBL] [Abstract][Full Text] [Related]
12. Assessment of changes in membrane properties of platelets from patients with chronic myeloid leukaemia in different stages of the disease.
Popov VM; Vladareanu AM; Bumbea H; Kovacs E; Moisescu MG; Onisai M; Iordache MM; Savopol T
Blood Coagul Fibrinolysis; 2014 Mar; 25(2):142-50. PubMed ID: 24346354
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects.
Gubert C; Stertz L; Pfaffenseller B; Panizzutti BS; Rezin GT; Massuda R; Streck EL; Gama CS; Kapczinski F; Kunz M
J Psychiatr Res; 2013 Oct; 47(10):1396-402. PubMed ID: 23870796
[TBL] [Abstract][Full Text] [Related]
14. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of lipid peroxidation related to hypertension in aging.
Yavuzer H; Yavuzer S; Cengiz M; Erman H; Doventas A; Balci H; Erdincler DS; Uzun H
Hypertens Res; 2016 May; 39(5):342-8. PubMed ID: 26763852
[TBL] [Abstract][Full Text] [Related]
16. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma.
Lapenna D; Ciofani G; Pierdomenico SD; Giamberardino MA; Cuccurullo F
Free Radic Biol Med; 2001 Aug; 31(3):331-5. PubMed ID: 11461770
[TBL] [Abstract][Full Text] [Related]
17. Thiobarbituric acid reactive substances (TBARS) is a state biomarker of oxidative stress in bipolar patients in a manic phase.
Tsai MC; Huang TL
J Affect Disord; 2015 Mar; 173():22-6. PubMed ID: 25462391
[TBL] [Abstract][Full Text] [Related]
18. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
[TBL] [Abstract][Full Text] [Related]
19. CR-LAAO antileukemic effect against Bcr-Abl(+) cells is mediated by apoptosis and hydrogen peroxide.
Burin SM; Ghisla S; Ouchida AT; Aissa AF; Coelho MG; Costa TR; Marsola AP; Pinto-Simões B; Antunes LM; Curti C; Sampaio SV; de Castro FA
Int J Biol Macromol; 2016 May; 86():309-20. PubMed ID: 26812110
[TBL] [Abstract][Full Text] [Related]
20. [STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia].
Meng FY; Zheng WY; Liu XL; Xu B; Song LL; Zhang Y; Huang F
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1149-50. PubMed ID: 14625174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
